kenvue board of directors

News

Tylenol, Kenvue

Tylenol maker Kenvue ousts CEO amid board's strategic review

Band-Aid and Tylenol maker Kenvue has fired its CEO Thibaut Mongon, the consumer health company said on Monday, laying what some investors expect will be the groundwork for an eventual sale of the entire company or pieces of it.

Cosmetics Business · 2d

Kenvue ousts CEO and launches strategic review amid struggling sales

· 3d

Tylenol-maker Kenvue fires CEO Thibaut Mongon, hires Kirk Pery as interim CEO

Business Wire3d

Kenvue Announces CEO Transition and Actions to Unlock Shareholder Value

Kenvue Inc. (NYSE: KVUE) today announced that its Board of Directors is implementing a set of actions to enable the Company ...

Fierce Pharma2d

Consumer health giant Kenvue kicks off CEO transition as sales slip

With activist investor Starboard Value holding a seat on Kenvue’s board of directors, the consumer healthcare company is ...

Medical Marketing & Media6h

The Escalator: Johnson & Johnson MedTech, Jazz Pharmaceuticals, Kenvue and more

Inventiva named Jason Campagna as president of R&D and chief medical officer, and Martine Zimmermann as EVP of regulatory affairs and quality assurance. Evolent named Dr. David Lim as chief clinical ...

3don MSN

Kenvue appoints Kirk Perry as interim CEO, sees Q2 adjusted EPS of $0.28 to $0.29

Kenvue (KUVE) has named Kirk Perry, a current director, as its interim CEO, effective immediately. Concurrently, Thibaut Mongon has left the company and resigned from the Kenvue Board. Perry, who ...

Beauty Packaging3d

Kenvue Announces CEO Transition

Current Kenvue Director, Kirk Perry, is named Interim CEO, effective immediately. Kenvue Board of Directors appointed a new ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results